#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15644	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2600	727.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1732	1732	C	934	C,G	933,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26134	23S	2890	2890	99.9	23S.l6.c17.ctg.1	4020	809.8	0	.	n	.	0	T695C	SNP	695	695	T	1293	1293	C	994	C,T	993,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26134	23S	2890	2890	99.9	23S.l6.c17.ctg.1	4020	809.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1935	1935	A	1097	A	1097	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26134	23S	2890	2890	99.9	23S.l6.c17.ctg.1	4020	809.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2569	2569	C	848	C	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26134	23S	2890	2890	99.9	23S.l6.c17.ctg.1	4020	809.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2643	2643	A	897	A,T	895,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26134	23S	2890	2890	99.9	23S.l6.c17.ctg.1	4020	809.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3195	3195	C	877	C,A,T,G	873,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2316	folP	852	852	100.0	folP.l15.c4.ctg.1	2248	128.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1382	1384	AGC	215;216;218	A;G;C	215;216;218	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6542	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3938	207.2	1	SNP	p	S91F	0	.	.	271	273	TCC	872	874	TCC	235;237;239	T;C;C,G	235;237;238,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6542	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3938	207.2	1	SNP	p	D95G	0	.	.	283	285	GAC	884	886	GAC	242;240;242	G;A;C	242;240;242	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6542	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3938	207.2	1	SNP	p	D95N	0	.	.	283	285	GAC	884	886	GAC	242;240;242	G;A;C	242;240;242	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2088	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1828	142.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	708	710	ACC	204;204;203	A;C,G;C	204;203,1;203	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2088	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1828	142.1	0	.	p	.	0	R44H	NONSYN	130	132	CGC	723	725	CAC	202;203;203	C,G;A;C	201,1;203;203	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2088	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1828	142.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	906	908	CAC	266;265;264	C;A;C	266;265;264	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2088	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1828	142.1	1	SNP	p	G45D	0	.	.	133	135	GGC	726	728	GGC	208;211;211	G;G;C	208;211;211	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1198	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1657	90.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4852	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3579	169.2	1	SNP	p	D86N	0	.	.	256	258	GAC	888	890	GAC	200;201;201	G;A;C,T	200;201;200,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4852	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3579	169.2	1	SNP	p	S87I	0	.	.	259	261	AGT	891	893	AGT	201;202;202	A,C;G;T	200,1;202;202	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4852	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3579	169.2	1	SNP	p	S87R	0	.	.	259	261	AGT	891	893	AGT	201;202;202	A,C;G;T	200,1;202;202	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4852	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3579	169.2	1	SNP	p	S87W	0	.	.	259	261	AGT	891	893	AGT	201;202;202	A,C;G;T	200,1;202;202	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4852	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3579	169.2	1	SNP	p	S88P	0	.	.	262	264	TCC	894	896	TCC	201;204;205	T;C;C	201;204;205	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4474	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3251	171.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1847	1849	GGC	258;256;252	G;G,A;C	258;255,1;252	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1539	1541	GCA	237;237;237	G;C,T;A,G	237;236,1;236,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1542	1544	ATC	235;237;235	A;T;C	235;237;235	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1554	1556	GTG	225;225;224	G,A;T;G	224,1;225;224	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1554	1556	GTG	225;225;224	G,A;T;G	224,1;225;224	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2058	2060	ACC	235;235;234	A,C;C;CGG,CG	234,1;235;226,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2112	2114	GCG	234;232;230	G;C;G	234;232;230	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2112	2114	GCG	234;232;230	G;C;G	234;232;230	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2235	2237	GGC	200;198;197	G;G,A;C	200;197,1;197	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2244	2246	GGC	208;205;206	G,T,A;G;C	206,1,1;205;206	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4070	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2950	172.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2262	2264	CCG	214;216;212	C;C,G;G	214;215,1;212	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5046	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3675	171.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1933	1935	CTG	186;188;189	C;T,A;G,T	186;187,1;188,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3170	porA	1146	1146	99.83	porA.l15.c17.ctg.1	2457	161.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	995	995	C	216	C,A	215,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	921	923	ATT	234;231;230	A,G;T;T	233,1;231;230	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	963	965	AGC	200;197;198	A,C;G,C;C	199,1;196,1;198	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	990	992	ATC	169;165;165	A;T;C,A	169;165;164,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	1055	1056	CG	180;180	C,A;G,T	179,1;179,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	1058	1060	CAG	182;181;183	C;A;G	182;181;183	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	1062	1064	AAA	182;182;182	A;A,T;A	182;181,1;182	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	1089	1091	TAT	203;200;199	T;A;T	203;200;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	1098	1100	GAG	207;209;211	G;A;G	207;209;211	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	V135F	NONSYN	403	405	GTG	1101	1103	TTT	210;210;211	T;T,A;T	210;209,1;211	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	1116	1118	AAA	217;216;217	A;A,C;A,G	217;215,1;216,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	1125	1127	GAA	215;216;218	G;A;A	215;216;218	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1149	1151	GCA	208;208;207	G;C;A	208;208;207	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1335	1337	TCA	235;237;238	T,A,G;C,T;A	233,1,1;236,1;238	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1455	1457	CAA	157;156;155	C;A;A	157;156;155	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	.	INDELS	760	762	ACA	1459	1463	ATCAA	154;151;145;146;146	A,T,C;T;C;A,T;A	152,1,1;151;145;144,2;146	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	.	INDELS	763	764	TG	1466	1468	AGT	147;148;146	A;G;T,A	147;148;145,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1473	1475	GAT	142;145;146	G,C;A;T	141,1;145;146	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	D292N	NONSYN	874	876	GAT	1578	1580	AAT	187;182;182	A;A;T,G	187;182;181,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1581	1583	AGT	185;184;187	A;G;T	185;184;187	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1587	1589	GAC	194;196;195	G;A;C	194;196;195	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1590	1592	TAC	197;199;199	T;A;C	197;199;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	1	SNP	p	G120K	1	.	.	358	360	AAG	1055	1057	CGG	180;180;182	C,A;G,T;G	179,1;179,1;182	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	1	SNP	p	D121N	0	.	.	361	363	GAC	1058	1061	CGC	182;183;183	C;G;C	182;183;183	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2428	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	1970	152.6	1	SNP	p	A121D	1	.	.	361	363	GAC	1058	1061	CGC	182;183;183	C;G;C	182;183;183	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	228	porB3	990	162	93.21	porB3.l15.c30.ctg.1	164	54.1	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	71;71;71	A;C;T	71;71;71	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	228	porB3	990	162	93.21	porB3.l15.c30.ctg.1	164	54.1	0	.	p	.	0	D275N	NONSYN	823	825	GAT	68	70	AAT	71;71;71	A;A;T,G	71;71;70,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	228	porB3	990	162	93.21	porB3.l15.c30.ctg.1	164	54.1	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	71;71;71	A;G;T	71;71;71	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	228	porB3	990	162	93.21	porB3.l15.c30.ctg.1	164	54.1	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	71;71;71	G;A;C	71;71;71	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	228	porB3	990	162	93.21	porB3.l15.c30.ctg.1	164	54.1	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	71;71;71	T;A;C	71;71;71	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9052	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	5494	205.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2268	2270	CAT	227;226;227	C;A;T,G	227;226;226,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1396	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1480	117.5	1	SNP	p	V57M	1	.	.	169	171	ATG	733	735	ATG	238;237;237	A;T;G	238;237;237	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
